FDA
approval
· 2023-07-05
FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)
Summary
FDA approved Sandoz's supplemental application for GLATOPA, a generic glatiramer acetate product, for use in treating multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLATOPA (GLATIRAMER ACETATE)